Yilmaz, C. Et Al. 2021. Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , vol.394, no.11 , 2259-2272.

Yilmaz, C., KÖKSOY, S., Ceker, T., & Aslan, M., (2021). Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , vol.394, no.11, 2259-2272.

Yilmaz, Cagatay Et Al. "Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells," NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , vol.394, no.11, 2259-2272, 2021

Yilmaz, Cagatay Et Al. "Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells." NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , vol.394, no.11, pp.2259-2272, 2021

Yilmaz, C. Et Al. (2021) . "Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells." NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY , vol.394, no.11, pp.2259-2272.

@article{article, author={Cagatay Yilmaz Et Al. }, title={Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells}, journal={NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY}, year=2021, pages={2259-2272} }